Quadria Cap concludes Rs 475.31 crore investment in ConcordPrivate equity firm Quadria Capital has concluded a Rs 475.31 crore investment in biopharmaceutical active ingredient manufacturer Concord ...
- Concord Biotech plans overseas foray, invest $20 million
Ahmedabad-based Concord Biotech will invest $20 million in setting up a fermentation facility abroad to save on power and fuel costs.
- B'desh labour unrest may divert garment orders to India
The ongoing labour strife in Bangladesh over minimum wages may rob the country of its cost-advantage and prove to be a boon for the Indian ...
- Mylan sells stake in Concord Biotech
World’s second-largest generic drug maker Mylan, which held a majority stake in Ahmedabad-based Concord Biotech through its subsidiary Matr...
- Slowdown woes: Indian apparel exporters iron out inherent problems
Indian apparel exporters are battling not only recession blues, but also their more competitive rivals in Bangladesh and Vietnam. The indus...
- Textile industry moving beyond 'quota blues'
The quota regime is over, leaving the textile sector with many opportunities to enhance its overall competitiveness.
- Science of entrepreneurship
"I always wanted to become an entrepreneur. And I knew biotech would be the next big thing. I was apprehensive. But I told myself, let me d...
- Gujarat next biotech hub, number of cos up 50%
Big pharma companies such as Zydus Healthcare plans to focus on biotech in a big way.
- M&As help small pharma cos make it big
Concord Biotech, a small Ahmedabad-based biotechnology firm, on Tuesday shipped its first consignment to its new $1.2bn US-based parent, My...